Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +41 | +3.99% | $0.00 | 1.07K | Sep 1, 2023 | Direct | F1 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$6.71K | -17 | -1.59% | $394.60 | 1.05K | Sep 1, 2023 | Direct | |
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +30 | +2.85% | $0.00 | 1.08K | Sep 1, 2023 | Direct | F1 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$4.74K | -12 | -1.11% | $394.60 | 1.07K | Sep 1, 2023 | Direct | |
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +44 | +4.12% | $0.00 | 1.11K | Sep 2, 2023 | Direct | F1 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$7.1K | -18 | -1.62% | $394.60 | 1.1K | Sep 2, 2023 | Direct | |
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +56 | +5.11% | $0.00 | 1.15K | Sep 3, 2023 | Direct | F1 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$9.08K | -23 | -2% | $394.60 | 1.13K | Sep 3, 2023 | Direct | |
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +82 | +7.27% | $0.00 | 1.21K | Sep 4, 2023 | Direct | F1 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$13.4K | -34 | -2.81% | $394.60 | 1.18K | Sep 4, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO | Restricted Stock Units | Award | $0 | +298 | $0.00 | 298 | Sep 1, 2023 | Bio-Rad A Common Stock | 298 | $0.00 | Direct | F2, F3 | |
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -41 | -24.55% | $0.00 | 126 | Sep 1, 2023 | Bio-Rad A Common Stock | 41 | $0.00 | Direct | F2, F4 |
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -30 | -32.61% | $0.00 | 62 | Sep 1, 2023 | Bio-Rad A Common Stock | 30 | $0.00 | Direct | F2, F5 |
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -44 | -50% | $0.00 | 44 | Sep 2, 2023 | Bio-Rad A Common Stock | 44 | $0.00 | Direct | F2, F6 |
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -56 | -50% | $0.00 | 56 | Sep 3, 2023 | Bio-Rad A Common Stock | 56 | $0.00 | Direct | F2, F7 |
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -82 | -100% | $0.00* | 0 | Sep 4, 2023 | Bio-Rad A Common Stock | 82 | $0.00 | Direct | F2, F8 |
Id | Content |
---|---|
F1 | Shares of Class A common stock acquired on the vesting of restricted stock units. |
F2 | Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. |
F3 | The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
F4 | On September 1, 2022, the reporting person was granted 167 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F5 | On September 1, 2021, the reporting person was granted 122 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F6 | On September 2, 2020, the reporting person was granted 174 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F7 | On September 3, 2019, the reporting person was granted 279 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |
F8 | On September 4, 2018, the reporting person was granted 410 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |